AI in healthcare a new law: [South Korea] New Digital Device Law for AI in Healthcare

AI in healthcare new regulation

AI in healthcare a new law: New Regulations for AI-Integrated Medical Devices

AI in healthcare a new law: As technology advances, so does the regulation of digital medical devices. If you’re involved in the medical device industry, you need to be aware of the upcoming changes due to the new Digital Medical Device Law in South Korea. This law impacts devices with integrated artificial intelligence (AI) and independent software medical devices.

Key Changes in the Digital Medical Device Law

On January 24, 2024, the Digital Medical Device Law will come into effect. What this means is:

  • New Approvals Needed: Medical devices with AI integrations must obtain a new product classification and approval.
  • Applies to Embedded Software: Devices with embedded software functioning as a medical device will also need new classifications.
  • Around 800 Products Affected: The Ministry of Food and Drug Safety (MFDS) is contacting companies with products requiring compliance.

Why This Matters

The changes aim to bring clarity and structure to the regulation of digital medical devices by:

  • Addressing the rapid integration of AI in medical devices.
  • Ensuring these devices meet rigorous safety and performance standards.
  • Aligning with global regulations for high-impact AI systems.

Separate Management for Embedded AI

According to the MFDS, devices like CT, MRI, X-ray machines with AI for diagnostic support also need new approval. Previously, only standalone devices needed such scrutiny. Now:

  • CT, MRI, X-ray: If they have embedded AI, they fall under the new law.
  • Supplementary Diagnostic Functions: Any AI offering diagnostic support must undergo evaluation and approval.

Transition and Implementation

The MFDS plans to assist companies through this transition by:

  • Individual Notices: Companies will receive notifications by the end of the month regarding required changes.
  • Guidelines and Support: Administrative announcements will act as references for defining digital medical devices.

Industry Response

A mix of anticipation and relief greets this law:

  • Clear Guidelines: Industry representatives appreciate clearer regulatory paths.
  • Input Considered: Representatives listen to feedback from health associations and businesses during the law’s formation phase.

Steps Moving Forward

For compliance, companies and developers in the digital healthcare and medical device sectors should:

  1. Review Device Classifications: Understand how devices will be classified under the new law.
  2. Prepare for New Approvals: Gather necessary documentation and data for new approval processes.
  3. Stay Informed: Keep up with further communications from the MFDS about transitioning.

Assistance and Resources

The MFDS has committed to broad support, including:

  • Call Centers: To help companies with questions about compliance.
  • Certification Agencies: Designating organizations to handle certification and quality management processes.

Conclusion

As South Korea introduces the Digital Medical Device Law, businesses must adjust to new regulatory standards. This includes reevaluating devices with AI to secure proper approvals and classifications. By understanding these requirements, you can stay compliant and competitive in a rapidly evolving healthcare sector.

Table of Contents:

  1. Introduction
    • Overview of the Digital Medical Device Law
    • Importance of understanding new regulations for AI-integrated devices
  2. Key Changes in the Digital Medical Device Law
    • Effective date: January 24, 2024
    • New approvals and product classifications required
    • Impact on embedded software medical devices
  3. Why This Matters
    • The need for clarity in the regulation of digital medical devices
    • Ensuring safety and performance standards for AI-integrated products
    • Alignment with global regulatory frameworks for high-impact AI systems
  4. Separate Management for Embedded AI
    • New approval requirements for AI-supported diagnostic machines
    • Overview of impacted devices (CT, MRI, X-ray)
    • Evaluation guidelines for supplementary diagnostic functions
  5. Transition and Implementation
    • Overview of the MFDS support for companies during the transition
    • Notification procedures for companies regarding required changes
    • Reference materials for defining digital medical devices
  6. Industry Response
    • Anticipation and relief within the medical device industry
    • Received feedback from health associations during the law’s formation
  7. Steps Moving Forward
    • Reviewing device classifications based on the new law
    • Preparing necessary documentation for new approval processes
    • Staying informed through MFDS communications
  8. Assistance and Resources
    • Overview of MFDS support services for compliance
    • Role of certification agencies in the regulatory process
  9. Conclusion
    • Importance of adapting to the Digital Medical Device Law
    • Encouragement to understand requirements for compliance and competitiveness
Scroll to Top